Sr. Director, Business Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Acadia Pharmaceuticals Inc. · 1 week ago

Sr. Director, Business Development

Acadia Pharmaceuticals is committed to meaningful innovation for underserved neurological and rare disease communities. The Senior Director of Business Development will lead a team to identify and evaluate external assets to enhance Acadia's portfolio, focusing on in-licensing and strategic collaborations within the biopharma industry.

BiotechnologyHealth CarePharmaceutical
Hiring Manager
Ben Grieser
linkedin

Responsibilities

Effectively manages the transaction process (approach, opportunity assessment, due diligence, valuation, deal negotiations, deal structuring, internal governance processes, closing process and integration planning for key initiatives). Develop a solid business case for each transaction
Drives search efforts to identify business development acquisition or in-licensing opportunities
Performs in-depth evaluations, interpreting competitive landscape and analysis of financial data
Assembles and effectively utilizes internal and external resources (as necessary) to ensure adequate support for each transaction
Works closely with the senior business development leadership to lead and/or assist in developing negotiation strategies
Works with Finance to create forecasting and deal evaluation models
Works with Legal to draft and negotiate contracts for transactions
Role supports and coordinates all deal-related activities for potential transactions. The External Innovation and Commercial teams lead the scientific and commercial assessments, which are incorporated into the overall deal package by BD
Maintains awareness and knowledge of product strategy to assess fit of potential candidates
Stays abreast of emerging healthcare & pharmaceutical industry trends and assess their potential impact on business strategies
Cultivates and maintains positive relationships with biopharma companies, venture capitalists, investment bankers, and industry executives

Qualification

Business DevelopmentPharmaceutical Industry KnowledgeFinancial AnalysisNegotiationScientific KnowledgeMS Office SuiteLeadershipCritical ThinkingCommunication SkillsProject Management

Required

Educational background in a scientific discipline is preferred, while an advanced scientific degree e.g. PhD is highly preferred
A minimum of 12 years of progressively responsible experience within Business Development or investment banking with a focus on in-licensing or acquisition of therapeutics/companies in the pharmaceutical or biotech industry
A combination of relevant education and applicable job experience may be considered
Prior experience within neurology and/or rare disease therapeutic areas is strongly preferred
Substantial and varied transaction as well as negotiation experience
Plays a key role leading and supporting numerous in-licensing, out-licensing, strategic collaboration, commercial alliance and acquisition transactions
Possesses robust experience identifying, negotiating and closing transactions
Scientific knowledge of industry sub-segments of CNS, Neurology or Orphan/Rare disease as well as industry functional areas of R&D, Clinical Development and Medical Affairs
Proven ability to lead in a complex matrix environment with and without direct authority
Demonstrated leadership abilities in direct and cross-functional roles
Critical thinking skills with the ability to get to the right level of granularity to balance speed of execution and facilitate optimal decision-making by executive management
Excellent financial analysis and research skills and ability to translate analyses into sound strategic recommendations
Skilled at negotiating with business partners or management and influencing senior level leaders regarding matters of significance to the organization
Strong understanding of pharmaceutical industry trends
Ability to work in a results-oriented, project-driven, real-time team environment, prioritize projects and deliver quality results within tight time constraints
Ability to think strategically as well as to act tactically
Ability to connect with people and work multi-culturally
Excellent written and verbal communication, presentation skills and MS Office Suite and database skills
Ability to travel extensively within and outside of the U.S

Benefits

Competitive base, bonus, new hire and ongoing equity packages
Medical, dental, and vision insurance
Employer-paid life, disability, business travel and EAP coverage
401(k) Plan with a fully vested company match 1:1 up to 5%
Employee Stock Purchase Plan with a 2-year purchase price lock-in
15+ vacation days
13 -15 paid holidays, including office closure between December 24th and January 1st
10 days of paid sick time
Paid parental leave benefit
Tuition assistance

Company

Acadia Pharmaceuticals Inc.

twittertwittertwitter
company-logo
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

Funding

Current Stage
Public Company
Total Funding
$811.73M
Key Investors
National Institute of Neurological Disorders and StrokeOxford Bioscience PartnersNational Institute of Mental Health
2019-09-17Post Ipo Equity· $287.5M
2018-11-30Post Ipo Equity· $316.25M
2013-01-02Post Ipo Equity· $86.39M

Leadership Team

leader-logo
Catherine Adams
Chief Executive Officer
linkedin
leader-logo
Steve Davis
President and CEO
linkedin
Company data provided by crunchbase